Kylie Snow

Kylie Snow

Knobbe Martens

Contact
View Bio
RSS

Latest Publications

Share:

Practical Application and Particular Treatment: What the USPTO’s December 4 Memorandum Means for Life Sciences §101 Eligibility

The USPTO’s December 4, 2025 memorandum on Subject Matter Eligibility Declarations (SMEDs) seeks to raise awareness of the “underutilized path” of submitting Rule 132 declarations, referred to as “SMEDs”, for supporting §101...more

2/10/2026  /  Alice/Mayo , Biotechnology , Life Sciences , Patent Applications , Patent Examinations , Patent Prosecution , Patent-Eligible Subject Matter , Patents , Pharmaceutical Patents , USPTO
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide